As of May 27, 2025, BioInvent International AB (BINV.ST) reports a EV/EBITDA of -3.61.
EV/EBITDA evaluates a company's total value relative to its earnings before interest, taxes, depreciation, and amortization, useful for comparing firms with different capital structures.
Comparing BioInvent International AB's EV/EBITDA to Peers
To better understand BioInvent International AB's position, it's useful to compare its EV/EBITDA against industry peers. Below are selected comparisons:
| Company | EV/EBITDA |
|---|---|
| BioInvent International AB (BINV.ST) | -3.61 |
| Bonesupport Holding AB (BONEX.ST) | 100.47 |
| Probi AB (PROB.ST) | 35.44 |
| Blirt SA (BLR.WA) | 28.24 |
| Oxurion NV (OXUR.BR) | 21.45 |
| Vitrolife AB (VITR.ST) | 20.35 |
Compared to its competitors, BioInvent International AB's EV/EBITDA is about average compared to peers, indicating market valuation in line with industry expectations.